Media
Latest News
New Haven, CT – Congresswoman Rosa L. DeLauro (CT-3) issued the following statement in advance of Saturday's official naming ceremony for the Maurice Rose Armed Forces Reserve Center in Middletown.
New Haven, CT — Congresswoman Rosa L. DeLauro and Senator Richard Blumenthal praised the award of a $2,855,069 grant to the New Haven Jewish Federation Housing Corporation from the U.S. Department of Housing and Urban Development's Assisted Living Conversion Program.
New Haven, CT – Congresswoman Rosa L. DeLauro (CT-3) issued the following statement in advance of Saturday's official naming ceremony for the Maurice Rose Armed Forces Reserve Center in Middletown.
WASHINGTON, DC – With the former head of the now-defunct MF Global set to testify on Capitol Hill today, Reps.
WASHINGTON, DC – With the former head of the now-defunct MF Global set to testify on Capitol Hill today, Reps.
New Haven, CT — Congresswoman Rosa L. DeLauro and Senator Richard Blumenthal praised the award of a $2,855,069 grant to the New Haven Jewish Federation Housing Corporation from the U.S. Department of Housing and Urban Development's Assisted Living Conversion Program.
New Haven, CT— Congresswoman Rosa DeLauro (CT-3) released the following statement today in response to the report from Witt Associates on the utility companies' response to the October snowstorm.
New Haven, CT— Congresswoman Rosa DeLauro (CT-3) released the following statement today in response to the report from Witt Associates on the utility companies' response to the October snowstorm.
Dear Inspector General Levinson:
I write to ask that you review the adequacy of the reimbursement rates established in the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 and their affect on physician practices' ability to obtain drugs and biologicals for the treatment of cancer patients.
Washington, DC – Congresswoman Rosa L. DeLauro (CT-3), Ranking Member on the Labor, Health, and Human Services Appropriations Subcommittee, called on the Inspector General of the Department of Health & Human Services to review Medicare physician reimbursement rates and their impact on access to drugs for cancer patients.